HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.

Deadlines:

  • Letters of Intent Receipt Date(s): 30 days prior to the application due date.
  • AIDS Application Due Date(s): March 13, 2024; March 13, 2025; March 13, 2026

PAR-24-037 Expiration Date: March 14, 2026

Agency Website

Amount

$12,500,000

Amount Description

Application budgets are not expected to exceed $2,500,000 in direct costs per year and should reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. The maximum project period is 5 years. 

    Funding Type

    Grant

    Eligibility

    Faculty

    Category

    Interdisciplinary
    Medical
    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational

    External Deadline

    March 13, 2024